COc1ccc2c(c1)c1nn(CCN3CCCCC3)c3ccc4c(=O)n(CCN(C)C)c(=O)n2c4c13.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?